2000
DOI: 10.1016/s0378-4274(99)00247-7
|View full text |Cite
|
Sign up to set email alerts
|

Ah receptor ligands and tumor promotion: survival of neoplastic cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
29
0
1

Year Published

2000
2000
2016
2016

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 63 publications
(30 citation statements)
references
References 45 publications
0
29
0
1
Order By: Relevance
“…The carcinogenic effect of polyaromatic hydrocarbons has been discussed in terms of Ah receptor-mediated induction of xenobiotic enzymes of the P450 system with subsequent production of active carcinogenic epoxides. [21] A number of agonists of the Ah receptor either act as direct tumour promoters [23] or play a role in the selection of malignant cells by preferential apoptosis of normal cells. [24] In contrast, agonists of the Ah receptor inducing apoptosis in malignant cells have been discussed as possible therapeutic agents for selective induction of cell death in malignant cells.…”
Section: Discussionmentioning
confidence: 99%
“…The carcinogenic effect of polyaromatic hydrocarbons has been discussed in terms of Ah receptor-mediated induction of xenobiotic enzymes of the P450 system with subsequent production of active carcinogenic epoxides. [21] A number of agonists of the Ah receptor either act as direct tumour promoters [23] or play a role in the selection of malignant cells by preferential apoptosis of normal cells. [24] In contrast, agonists of the Ah receptor inducing apoptosis in malignant cells have been discussed as possible therapeutic agents for selective induction of cell death in malignant cells.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, AHR activation by TCDD blocks UV irradiation-induced apoptosis (Worner and Schrenk, 1996;Schrenk et al, 2004). The capacity of various Ah receptor ligands to act as tumor promoters has been attributed to their ability to inhibit the apoptotic elimination of initiated cells bearing genotoxic lesions (Schwarz et al, 2000). Our data suggest that they may do so by activating the AHR and inhibiting apoptosis through repression of E2F1 proapoptotic target genes, thus preventing the elimination of cells that have lost normal cell cycle control and promoting their proliferation.…”
Section: Ahr-e2f1 Interaction Inhibits Apoptosismentioning
confidence: 99%
“…The overall effect of TCDD in this system is thus to accelerate the rate at which DNA-damaged cells convert to a neoplastic phenotype [Luebeck et al, 2000]. Stimulation of cell division in these assays is negligible [Buchmann et al, 1994], hence, the primary effect of TCDD is the inhibition of apoptosis, which has also been shown to occur in Myc transgenic mice [Buchmann et al, 1994;Schwarz et al, 2000] and in the promotion of ovarian tumors in rats [Davis et al, 2000a]. Absence of tumor promotion by TCDD treatment in rat strains lacking a functional AHR suggests that the Ah receptor is required for this effect, which has been shown to include activation of MDM2 and attenuation of p53 probably by increased ubiquitination [Viluksela et al, 2000;Paajarvi et al, 2005].…”
Section: Ahr-mediated Inhibition Of Apoptosismentioning
confidence: 99%